Megan Daniels, a 35-year-old solicitor from Liverpool, uses a neuromodulation device daily to stave off migraines. The device sends electric pulses to stimulate nerves in her neck and face, providing a soothing sensation. She is among the more than one billion people worldwide affected by this debilitating neurological condition.
New research is yielding an array of novel therapies for migraine sufferers, including Botox injections and devices that vibrate the nose. These treatments aim to prevent attacks or halt them in their tracks. Neurologist Narayan Kissoon of the Mayo Clinic notes that treatment options have expanded dramatically in the past decade.
Despite these advances, treating migraine remains complex. The condition varies widely among patients, with symptoms ranging from throbbing headaches to nausea and visual disturbances. Three-quarters of sufferers are women, and children can also be affected. Overuse of painkillers can worsen the problem, leading to chronic migraine.
Doctors have repurposed medications like cardiac drugs and antidepressants for migraine prevention, though side effects can be significant. As researchers continue to unravel the mysteries of migraine, patients like Daniels find hope in emerging therapies tailored to their individual needs.
